01Jan
January 6, 2016
Cabinet Barny advised Enterome on the conclusion of a collaborative research and development agreement with Takeda, with an exclusive licence option to the benefit of Takeda, to develop therapeutics directed at microbiome targets for the treatment of gastrointestinal disorders.
http://www.enterome.fr/site/wp-content/uploads/2016/01/PR_Enterome_Takeda_EN.pdf